1. [Tryptase: A practical guide for the physician].
- Author
-
Lobbes H, Reynaud Q, Mainbourg S, Lega JC, Durieu I, and Durupt S
- Subjects
- Anaphylaxis blood, Anaphylaxis diagnosis, Blood Chemical Analysis methods, Bone Marrow pathology, Humans, Mast Cells pathology, Mastocytosis blood, Mastocytosis diagnosis, Mastocytosis, Systemic blood, Mastocytosis, Systemic diagnosis, Physicians standards, Reference Values, Tryptases analysis, Blood Chemical Analysis standards, Education, Medical, Continuing standards, Practice Guidelines as Topic, Practice Patterns, Physicians' standards, Tryptases blood
- Abstract
Tryptase is the most abundant endopeptidase released by mast cells degranulation, involved in many pro and anti-inflammatory processes. Normal serum tryptase range is 0-11.4 μg/L. Tryptase is a useful diagnostic tool for anaphylaxis, systemic mastocytosis (SM) and mast cell activation syndrome (MCAS), where specific threshold values must be used. SM diagnosis criteria include evidence of dense mast cell infiltrate either in the bone marrow or the affected organ (such as skin), presence of KIT D816V mutation and elevated serum tryptase level (>20 μg/L). In SM, tryptase level is correlated with the burden of mast cells in bone marrow. MCAS should be considered in case of severe and recurrent typical clinical signs of systemic mast cell activation involving at least two organs, associated with an increase in serum tryptase level of 20% + 2 μg/L from the individual's baseline. Anaphylaxis is the most severe among hypersensitivity reactions. A clonal mast cell disorder is a central question in anaphylaxis and appropriate explorations should be conducted in these patients. Triggers for anaphylactic reactions vary significantly in the general population and in patients with MS or MCAS. Finally, physicians must be aware of the many pathological and physiological situations that affect tryptase levels., (Copyright © 2020. Published by Elsevier Masson SAS.)
- Published
- 2020
- Full Text
- View/download PDF